Full Press Release Details
TARRYTOWN, N.Y.,Dec. 17, 2013/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast its presentation at the 32ndAnnual J. P. Morgan Healthcare Conference onTuesday, January 14, 2014. The presentation is scheduled for7:30 a.m. Pacific Time(10:30 a.m. Eastern Time) and may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentation will be available for 30 days.
About Regeneron PharmaceuticalsRegeneron is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visitwww.regeneron.com.
| Manisha Narasimhan, Ph.D. | Peter Dworkin |
| Investor Relations | Corporate Communications |
| 914.847.5126 | 914.847.7640 |
| [email protected] | [email protected] |
Manisha Narasimhan, Ph.D.
Peter Dworkin
Investor Relations
Corporate Communications
914.847.5126
914.847.7640
[email protected]
[email protected]